Capital Research Global Investors’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $87.5M | Buy |
1,159,132
+8,083
| +0.7% | +$576K | 0.01% | 321 |
|
|
2025
Q4 | $71M | Buy |
1,151,049
+7,784
| +0.7% | +$458K | 0.01% | 325 |
|
|
2025
Q3 | $67.1M | Buy |
1,143,265
+9,488
| +0.8% | +$553K | 0.01% | 326 |
|
|
2025
Q2 | $66M | Buy |
1,133,777
+7,549
| +0.7% | +$427K | 0.01% | 323 |
|
|
2025
Q1 | $55.9M | Buy |
1,126,228
+2,050
| +0.2% | +$105K | 0.01% | 350 |
|
|
2024
Q4 | $50.3M | Buy |
1,124,178
+3,589
| +0.3% | +$170K | 0.01% | 356 |
|
|
2024
Q3 | $53.9M | Hold |
1,120,589
| – | – | 0.01% | 332 |
|
|
2024
Q2 | $57M | Hold |
1,120,589
| – | – | 0.01% | 325 |
|
|
2024
Q1 | $60.9M | Buy |
1,120,589
+906
| +0.1% | +$47.2K | 0.01% | 327 |
|
|
2023
Q4 | $63.1M | Hold |
1,119,683
| – | – | 0.02% | 306 |
|
|
2023
Q3 | $69.2M | Buy |
1,119,683
+572
| +0.1% | +$36.2K | 0.02% | 301 |
|
|
2023
Q2 | $66.1M | Buy |
1,119,111
+510
| +0% | +$32.5K | 0.02% | 310 |
|
|
2023
Q1 | $82.6M | Buy |
1,118,601
+541
| +0% | +$41.7K | 0.02% | 290 |
|
|
2022
Q4 | $81.7M | Hold |
1,118,060
| – | – | 0.02% | 293 |
|
|
2022
Q3 | $93.2M | Sell |
1,118,060
-2,013,238
| -64% | -$173M | 0.03% | 267 |
|
|
2022
Q2 | $250M | Sell |
3,131,298
-964
| -0% | -$93.6K | 0.08% | 189 |
|
|
2022
Q1 | $326M | Buy |
3,132,262
+394
| +0% | +$32.6K | 0.08% | 192 |
|
|
2021
Q4 | $236M | Sell |
3,131,868
-462
| -0% | -$32.3K | 0.05% | 234 |
|
|
2021
Q3 | $203M | Buy |
3,132,330
+472
| +0% | +$28.9K | 0.05% | 249 |
|
|
2021
Q2 | $190M | Sell |
3,131,858
-2,329,783
| -43% | -$138M | 0.04% | 251 |
|
|
2021
Q1 | $294M | Sell |
5,461,641
-630,063
| -10% | -$34.3M | 0.07% | 213 |
|
|
2020
Q4 | $293M | Buy |
6,091,704
+3,248
| +0.1% | +$144K | 0.08% | 206 |
|
|
2020
Q3 | $239M | Buy |
6,088,456
+2,181
| +0% | +$79.4K | 0.07% | 199 |
|
|
2020
Q2 | $195M | Buy |
6,086,275
+29,811
| +0.5% | +$1.04M | 0.06% | 210 |
|
|
2020
Q1 | $206M | Sell |
6,056,464
-3,207,338
| -35% | -$128M | 0.08% | 185 |
|
|
2019
Q4 | $444M | Buy |
9,263,802
+6,251
| +0.1% | +$302K | 0.13% | 151 |
|
|
2019
Q3 | $462M | Buy |
9,257,551
+1,608
| +0% | +$82.1K | 0.15% | 139 |
|
|
2019
Q2 | $495M | Buy |
9,255,943
+7,815
| +0.1% | +$408K | 0.16% | 135 |
|
|
2019
Q1 | $488M | Buy |
9,248,128
+1,631
| +0% | +$85K | 0.15% | 133 |
|
|
2018
Q4 | $435M | Sell |
9,246,497
-1,824,992
| -16% | -$95.2M | 0.15% | 137 |
|
|
2018
Q3 | $639M | Sell |
11,071,489
-1,367,125
| -11% | -$75.7M | 0.19% | 116 |
|
|
2018
Q2 | $676M | Buy |
12,438,614
+187
| +0% | +$9.28K | 0.18% | 118 |
|
|
2018
Q1 | $588M | Buy |
+12,438,427
| New | +$623M | 0.17% | 125 |
|
Other funds holding NTR
VCM
Capital Research Global Investors's NTR Position: Q1 2026 in Review
Capital Research Global Investors increased its Nutrien (NTR) stake by 0.7% in Q1 2026, buying an estimated $576K and bringing the position to 1,159,132 shares worth $87.5M. The position accounts for 0.01% of the portfolio, ranked #321.
Capital Research Global Investors first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $676M in Q2 2018. 748 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Capital Research Global Investors held 1,159,132 shares of Nutrien worth $87.5M as of Q1 2026.
- Capital Research Global Investors bought 8,083 Nutrien shares in Q1 2026, an estimated $576K.
- Nutrien made up 0.01% of Capital Research Global Investors's portfolio in Q1 2026, its #321 holding.
- Capital Research Global Investors first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Capital Research Global Investors's Nutrien position peaked at $676M in Q2 2018.
- 748 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.